{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:38:54Z","timestamp":1790595534566,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.peptides.2013.06.006","type":"journal-article","created":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T10:19:27Z","timestamp":1372155567000},"page":"167-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Decreased plasma nesfatin-1 levels in patients with acute myocardial infarction"],"prefix":"10.1016","volume":"46","author":[{"given":"Hongyan","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengzhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoudong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqing","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huamin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2013.06.006_bib0005","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00018-012-1138-7","article-title":"Nesfatin-1 as a novel cardiac peptide: identification, functional characterization, and protection against ischemia\/reperfusion injury","volume":"70","author":"Angelone","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.peptides.2013.06.006_bib0010","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.pnpbp.2010.12.004","article-title":"High plasma nesfatin-1 level in patients with major depressive disorder","volume":"35","author":"Ari","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.peptides.2013.06.006_bib0015","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11010-009-0073-x","article-title":"Nesfatin-1 and ghrelin levels in serum and saliva of epileptic patients: hormonal changes can have a major effect on seizure disorders","volume":"328","author":"Aydin","year":"2009","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.peptides.2013.06.006_bib0020","first-page":"48","article-title":"Plasma neuropeptide Y (NPY) and alpha-melanocyte stimulating hormone (a-MSH) levels in patients with or without hypertension and\/or obesity: a pilot study","volume":"1","author":"Baltazi","year":"2011","journal-title":"Am J Cardiovasc Dis"},{"key":"10.1016\/j.peptides.2013.06.006_bib0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.atherosclerosis.2006.03.003","article-title":"Leptin and atherosclerosis","volume":"189","author":"Beltowski","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.peptides.2013.06.006_bib0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-2094-6-27","article-title":"Central nesfatin-1-expressing neurons are sensitive to peripheral inflammatory stimulus","volume":"6","author":"Bonnet","year":"2009","journal-title":"J Neuroinflamm."},{"key":"10.1016\/j.peptides.2013.06.006_bib0035","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s12020-012-9638-7","article-title":"Nesfatin-1 and other hormone alterations in polycystic ovary syndrome","volume":"42","author":"Deniz","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.peptides.2013.06.006_bib0040","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0002-9149(83)80105-2","article-title":"A more meaningful scoring system for determining the severity of coronary heart disease","volume":"51","author":"Gensini","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.peptides.2013.06.006_bib0045","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.psyneuen.2012.04.007","article-title":"Decreased plasma nesfatin-1 levels in patients with generalized anxiety disorder","volume":"37","author":"Gunay","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.peptides.2013.06.006_bib0050","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.trsl.2010.01.004","article-title":"Serum levels of apelin and ghrelin in patients with acute coronary syndromes and established coronary artery disease\u2014Kozani study","volume":"155","author":"Kadoglou","year":"2010","journal-title":"Transl Res"},{"key":"10.1016\/j.peptides.2013.06.006_bib0055","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/1756-0500-5-262","article-title":"Elevated serum leptin levels in patients with acute myocardial infarction; correlation with coronary angiographic and echocardiographic findings","volume":"5","author":"Khafaji","year":"2012","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.peptides.2013.06.006_bib0060","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1210\/en.2007-1276","article-title":"Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding","volume":"149","author":"Kohno","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2013.06.006_bib0065","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.regpep.2009.11.003","article-title":"Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans","volume":"159","author":"Li","year":"2010","journal-title":"Regulatory peptides"},{"key":"10.1016\/j.peptides.2013.06.006_bib0070","doi-asserted-by":"crossref","first-page":"R1297","DOI":"10.1152\/ajpregu.00266.2011","article-title":"Nesfatin-1 influences the excitability of neurons in the nucleus of the solitary tract and regulates cardiovascular function","volume":"302","author":"Mimee","year":"2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.peptides.2013.06.006_bib0075","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.peptides.2010.10.004","article-title":"Plasma nesfatin-1 concentrations in restricting-type anorexia nervosa","volume":"32","author":"Ogiso","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2013.06.006_bib0080","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature05162","article-title":"Identification of nesfatin-1 as a satiety molecule in the hypothalamus","volume":"443","author":"Oh","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2013.06.006_bib0085","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neulet.2012.05.056","article-title":"Enhanced expression of nesfatin\/nucleobindin-2 in white adipose tissue of ventromedial hypothalamus-lesioned rats","volume":"521","author":"Osaki","year":"2012","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.peptides.2013.06.006_bib0090","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1227\/NEU.0b013e318210f258","article-title":"The novel function of nesfatin-1 as an anti-inflammatory and antiapoptotic peptide in subarachnoid hemorrhage-induced oxidative brain damage in rats","volume":"68","author":"Ozsavci","year":"2011","journal-title":"Neurosurgery"},{"key":"10.1016\/j.peptides.2013.06.006_bib0095","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1210\/en.2009-1358","article-title":"Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity","volume":"151","author":"Ramanjaneya","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2013.06.006_bib0100","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2174\/1570161053586868","article-title":"The emerging roles of leptin and ghrelin in cardiovascular physiology and pathophysiology","volume":"3","author":"Sharma","year":"2005","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.peptides.2013.06.006_bib0105","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1210\/en.2008-0598","article-title":"Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism","volume":"150","author":"Shimizu","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2013.06.006_bib0110","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.peptides.2011.07.006","article-title":"Lipopolysaccharide increases gastric and circulating NUCB2\/nesfatin-1 concentrations in rats","volume":"32","author":"Stengel","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2013.06.006_bib0115","doi-asserted-by":"crossref","first-page":"E669","DOI":"10.1210\/jc.2010-1782","article-title":"Decreased cerebrospinal fluid\/plasma ratio of the novel satiety molecule, nesfatin-1\/NUCB-2, in obese humans: evidence of nesfatin-1\/NUCB-2 resistance and implications for obesity treatment","volume":"96","author":"Tan","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.peptides.2013.06.006_bib0120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.peptides.2012.04.014","article-title":"The anti-inflammatory and anti-apoptotic effects of nesfatin-1 in the traumatic rat brain","volume":"36","author":"Tang","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2013.06.006_bib0125","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2265.2010.03835.x","article-title":"Fasting concentrations of nesfatin-1 are negatively correlated with body mass index in non-obese males","volume":"73","author":"Tsuchiya","year":"2010","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.peptides.2013.06.006_bib0130","doi-asserted-by":"crossref","first-page":"e45748","DOI":"10.1371\/journal.pone.0045748","article-title":"Serum acylated ghrelin concentrations in response to short-term overfeeding in normal weight, overweight, and obese men","volume":"7","author":"Wadden","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.peptides.2013.06.006_bib0135","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1248\/bpb.34.307","article-title":"Vascular effects of novel adipocytokines: focus on vascular contractility and inflammatory responses","volume":"34","author":"Yamawaki","year":"2011","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.peptides.2013.06.006_bib0140","doi-asserted-by":"crossref","first-page":"R330","DOI":"10.1152\/ajpregu.90867.2008","article-title":"Nesfatin-1 exerts cardiovascular actions in brain: possible interaction with the central melanocortin system","volume":"297","author":"Yosten","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.peptides.2013.06.006_bib0145","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ymgme.2011.03.007","article-title":"Association between polymorphisms of the Nesfatin gene, NUCB2, and obesity in men","volume":"103","author":"Zegers","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.peptides.2013.06.006_bib0150","doi-asserted-by":"crossref","first-page":"e54615","DOI":"10.1371\/journal.pone.0054615","article-title":"Association between serum leptin concentrations and insulin resistance: a population-based study from China","volume":"8","author":"Zuo","year":"2013","journal-title":"PLoS ONE"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978113002234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978113002234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T22:44:00Z","timestamp":1715553840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978113002234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":30,"alternative-id":["S0196978113002234"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2013.06.006","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased plasma nesfatin-1 levels in patients with acute myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2013.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}